TNXP
Tonix Pharmaceuticals Holding Corp
NASDAQ: TNXP · HEALTHCARE · BIOTECHNOLOGY
$12.93
+4.27% today
Updated 2026-04-30
Market cap
$183.68M
P/E ratio
—
P/S ratio
14.01x
EPS (TTM)
$-14.57
Dividend yield
—
52W range
$12 – $70
Volume
0.4M
Tonix Pharmaceuticals Holding Corp (TNXP) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
-896.00%
ROE
-64.50%
ROA
-35.70%
Debt/equity
0.00x
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2008 | — | $-21134.00 | — | — | — |
| 2009 | — | $-30866.00 | — | — | — |
| 2010 | — | $-17724.00 | — | — | — |
| 2011 | $0.00 | $-3.47M | — | — | — |
| 2012 | $1875.00 | $-9450.00 | -355,275.20% | -355,275.20% | -504.00% |
| 2013 | $0.00 | $-10.88M | — | — | — |
| 2014 | $0.00 | $-27.62M | — | — | — |
| 2015 | $0.00 | $-48.05M | — | — | — |
| 2016 | $0.00 | $-38.84M | — | — | — |
| 2017 | $0.00 | $-21.12M | — | — | — |
| 2018 | $0.00 | $-26.09M | — | — | — |
| 2019 | $0.00 | $-28.38M | — | — | — |
| 2020 | $2.91M | $-50.39M | -1,733.39% | -1,733.39% | -1,729.17% |
| 2021 | $0.00 | $-92.21M | — | — | — |
| 2022 | $9.03M | $-115.00M | -1,241.73% | -1,241.73% | -1,274.00% |
| 2023 | $7.77M | $-116.66M | 38.97% | -1,523.94% | -1,501.78% |
| 2024 | $10.09M | $-130.04M | 23.07% | -1,354.28% | -1,288.25% |
| 2025 | $13.11M | $-124.02M | 49.34% | -959.05% | -946.22% |